Cite

HARVARD Citation

    Picard, E. et al. (n.d.). 1356PThe level of circulating NKp46+ CD56dim CD16+ natural killer cells predicts distinct survival in non-small cell lung cancer. Annals of oncology. p. . [Online]. 
  
Back to record